Dr. Hirshburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Oklahoma HSC Dermatology
619 NE 13TH St
Oklahoma City, OK 73104Phone+1 405-271-4662Fax+1 405-271-4662
Education & Training
University of Texas Medical Branch HospitalsFellowship, Micrographic Surgery and Dermatologic Oncology, 2017 - 2018
University of Texas at Austin Dell Medical SchoolResidency, Dermatology, 2013 - 2017
University of Oklahoma College of MedicineClass of 2013
Certifications & Licensure
TX State Medical License 2017 - 2026
OK State Medical License 2018 - 2025- American Board of Dermatology Dermatology
Clinical Trials
- MC RCT - BPO vs Adapalene Start of enrollment: 2022 May 18
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 34 citationsMolecular basis for optical clearing of collagenous tissuesJason Hirshburg, Krishnakumar M. Ravikumar, Wonmuk Hwang, Alvin T. Yeh
Journal of Biomedical Optics. 2010-09-01 - 2 citationsSafety of Intradermal/Subcutaneous Lidocaine With Epinephrine Use in Dermatologic SurgeryJason M. Hirshburg, Dayna G. Diven, Chloe Edmiston, Susan E. Dozier, Meghan Woody
Dermatologic Surgery. 2020-01-01 - 80 citationsAdverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic ReviewHirshburg Jm, Kelsey Pa, Therrien Ca, Alde Carlo P. Gavino, Jason S. Reichenberg
The Journal of Clinical and Aesthetic Dermatology. 2016-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
